Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 23, 2016

View Archived Issues

Merck describes promising adenosine receptor A2a antagonists for treating Parkinson's disease

DS Biopharma spins out new company Afimmune

Exosomes encapsulating Alzheimer's disease biomarkers can be detected in plasma

Regeneron Pharmaceuticals signs agreement with BARDA for MERS research

AstraZeneca discloses potent capsid-binding human rhinovirus inhibitor AZN-001

European Commission grants marketing authorization to Gilead's Truvada

Pfizer set to acquire Medivation

Final phase IIa trial results for the first topical gel formulation of minocycline, BPX-01

Novel MST1/2 inhibitor stimulates tissue repair and regeneration in vivo

FORMA Therapeutics discloses ubiquitin hydrolase inhibitors

Gilead begins phase III program for filgotinib in rheumatoid arthritis

Trillium Therapeutics patents EGFR inhibitors

Novo Nordisk divulges neuropeptide Y receptor agonists

Sanford-Burnham Medical Research Institute reports glucocorticoid receptor translocation inhibitors

Emmaus will submit NDA to the FDA for its sickle disease therapy

VBI Vaccines will continue enrollment on its phase I trial evaluating cytomegalovirus vaccine

FDA grants fast track designation to AZD-3293 for the treatment of Alzheimer's disease

Amylyx Pharmaceuticals completes USD 5 million series A financing round

EMA validates marketing authorization for Puma's neratinib

Intelgenx completes study of montelukast using the Versafilm delivery technology

Phase II results for vemurafenib in patients with BRAF[V600E]-positive papillary thyroid cancer

FORMA Therapeutics patents HDAC 6 inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...